26/08/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

26/08/2024

Aug 26, 2024, 21:42 | Blog
Tanja Obradovic: Interesting update at ESMO 2024 on cancer-induced cachexia as PhII trial of ponsegromab
Tanja Obradovic posted on LinkedIn: “Interesting update will come at ESMO 2024 on possible option…
Aug 26, 2024, 21:39 | Blog
Article of the day suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute made the following post on LinkedIn: "Article of the day suggested…
Aug 26, 2024, 21:37 | Blog
Hundreds who walk, run and bike on Wilmot Warrior Weekend
Wilmot Cancer Institute shared a post on LinkedIn: “Wilmot Flashback Friday to 2013: Who remembers…
Aug 26, 2024, 21:36 | Blog
Real-World Analysis About Multiple Myeloma from the Balkan Myeloma Study Group (BMSG)
Balkan Myeloma Study Group made the following post on X: "Happy to announce! Another publication from…
Aug 26, 2024, 21:34 | Blog
4 Steering Group Member positions with the Young SIOP Network (YSN) Apply by Aug 31
SIOP International posted on X: “Nominations/self-nominations are welcome for 4 Steering Group Member positions with…
Aug 26, 2024, 21:33 | Blog
C. Ola Landgren: Lots of new data at the Hematology Society of Taiwan
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Aug 26, 2024, 21:30 | Blog
Tian Zhang: 3 weeks til ESMO24!
Tian Zhang shared a post by ESMO on X, adding the following: “T -3 weeks…
Aug 26, 2024, 21:28 | Blog
Patrick McGuire: Every step, every mile, every £ running cancer into the ground
Patrick McGuire, Ambassador at Cancer Research UK, shared a post on X: “With Team CRUK…
Aug 26, 2024, 21:25 | Blog
World Patient Safety Day Webinar on Diagnosis
World Patients Alliance made the following post on X: "World Patient Safety Day Webinar on Diagnosis…
Aug 26, 2024, 21:24 | Blog
Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC
Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…
All: 92 Posts: 1 - 10
Special Coverage